We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Role of Esophagectomy after Chemoradiation Therapy in Patients with Locally Advanced Squamous Cell Carcinoma: A Comparative Analysis Stratified by Clinical Response to Chemoradiation Therapy.
- Authors
Jesang Yu; Jong Hoon Kim; Sung-Bae Kim; Sook Ryun Park; Young-Hee Kim; Hyeong Ryul Kim; Hyun Joo Lee; Ho June Song; Kye Jin Song; Jeong Yun Jang; Yoon Young Jo; Ye Jin Yoo
- Abstract
Purpose This study aimed to evaluate the long-term effect of esophagectomy in patients with esophageal squamous cell carcinoma (ESCC) by comparing the chemoradiotherapy (CRT)-only group and the trimodality treatment (TMT) group who received concurrent CRT followed by surgery. Materials and Methods We included 412 operable ESCC patients treated with TMT or CRT between January 2005 and December 2015. The oncological outcomes of the two groups were compared using a weighted Cox proportional-hazards model with inverse probability of treatment weighting (IPTW). Results The median survival time was 64 and 32 months in the TMT (n=270) and CRT (n=142) groups, respectively (p < 0.001). After IPTW, the median overall survival (OS) remained significantly higher in the TMT group than in the CRT group (61 months vs. 32 months, p=0.016). Moreover, the TMT group showed a better local recurrence-free rate (LRFR; p < 0.001) and distant metastasis-free rate (p=0.007). In the subgroup of patients with clinical complete response (cCR), the OS was not significantly different between the two groups, both before and after IPTW adjustment (p=0.35 and p=0.93). However, among non-cCR patients, the OS was significantly higher in the TMT group (64% vs. 45%, p < 0.001). Conclusion In patients with locally advanced ESCC, TMT was superior to CRT in terms of OS and LRFR. Such difference was more prominent in the non-cCR subgroup. In patients who achieved cCR, esophagectomy was effective in improving LRFR but not OS, suggesting that esophagectomy may be omitted in complete responders.
- Subjects
SQUAMOUS cell carcinoma; CHEMORADIOTHERAPY; ESOPHAGECTOMY; ESOPHAGEAL cancer; TREATMENT effectiveness; SURVIVAL rate; COMPARATIVE studies
- Publication
Cancer Research & Treatment, 2022, Vol 54, Issue 4, p1148
- ISSN
1598-2998
- Publication type
Article
- DOI
10.4143/crt.2021.885